Serum Institute puts India trial of Astrazeneca's COVID-19 vaccine on hold following DCGI's notice
SII has stated that it paused trials of its experimental coronavirus vaccine.
Full Article
Serum Institute puts India trial of Astrazeneca's COVID-19 vaccine on hold following DCGI's notice
DNA
0 shares
1 views
You might like
Related news coverage
Foreign Secretary Harsh Vardhan Shringla’s Visit And India-Bangladesh Relations – Analysis
Eurasia Review
By Dr. Smruti S Pattanaik*
India and Bangladesh share a very close relationship. India played an important role in..
-
Serum Institute to manufacture 200mn doses of Covid-19 vaccine
Mid-Day
-
Adar Poonawalla: Will Govt have 80,000 crores available over the next one year?
Mid-Day
-
Mumbai: KEM hospital gets gets nod for COVID-19 vaccine trials
Mid-Day
-
COVID-19 vaccination to be available by 'start of next year': Harsh Vardhan
Mid-Day
Advertisement
More coverage
Serum Institute of India gets DCGI nod to resume clinical trial of Oxford COVID-19 vaccine
Mid-Day
Drugs Controller General of India (DCGI) Dr V G Somani on Tuesday gave permission to Serum Institute of India to resume clinical..
-
No shortage of medical oxygen for COVID-19 patients: Health Ministry
Mid-Day
-
COVID-19: India did not have huge peak at all, says ICMR DG
Mid-Day
-
COVID-19: India's role in production of vaccine critical in containing pandemic says Bill Gates
Mid-Day
-
For high-risk groups, government plans to fast-track vaccine
IndiaTimes